CAPELLO, ELISABETTA
CAPELLO, ELISABETTA
100009 - Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili
An eleven-year history of Vanishing White Matter Disease in an adult patient with no cognitive decline and EIF2B5 mutations. A case report
2021-01-01 Trevisan, L.; Grazzini, M.; Cianflone, A.; Accogli, A.; Finocchi, C.; Capello, E.; Saitta, L.; Grandis, M.; Roccatagliata, L.; Mandich, P.
Effect of ocrelizumab treatment on retinal atrophy: preliminary results from a single-center observational study
2022-01-01 Cellerino, M; Mancuso, E; Boffa, G; Bruschi, N; Novi, G; Magon, S; Gaetano, L; Uccelli, A; Capello, E; Laroni, A; Lapucci, C; Inglese, M
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population
2020-01-01 Boffa, G; Bruschi, N; Cellerino, M; Lapucci, C; Novi, G; Sbragia, E; Capello, E; Uccelli, A; Inglese, M.
Guillain barré syndrome of axonal type in a multple sclerosis patient: Fortuitous association or linked disorders?
1997-01-01 Roccatagliata, L.; Capello, E.; Schenone, A.; Inglese, M.; Nobbio, L.; Grandis, M.; Maritato, F.; Abbruzzese, M.; Mancardi, G. L.
Long-term assessment of the cognitive effects of nabiximols in patients with multiple sclerosis: A pilot study
2020-01-01 Alessandria, G.; Meli, R.; Infante, M. T.; Vestito, L.; Capello, E.; Bandini, F.
MRI and neuropathologic study of eae in the non human primate callithr1x jacchus
1997-01-01 Mancardi, G. L.; Capello, E.; Massacesi, L.; Inglese, M.; Giunti, D.; Nicolay, K.; 'T Hart, B. A.; Uccelli, A.
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?
2021-01-01 Tazza, F.; Lapucci, C.; Cellerino, M.; Boffa, G.; Novi, G.; Poire, I.; Mancuso, E.; Bruschi, N.; Sbragia, E.; Laroni, A.; Capello, E.; Inglese, M.
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
2021-01-01 Cellerino, M.; Boffa, G.; Lapucci, C.; Tazza, F.; Sbragia, E.; Mancuso, E.; Bruschi, N.; Minguzzi, S.; Ivaldi, F.; Poire, I.; Laroni, A.; Mancardi, G.; Capello, E.; Uccelli, A.; Novi, G.; Inglese, M.
Rapidly ascending necrotizing myelopathy with widespread brain white matter involvement following intrathecal methotrexate and cytosine arabinoside treatment in an adult with T cell acute lymphoblastic leukemia
2018-01-01 Lapucci, C; Capello, E; Romano, N; Guolo, F; Mavilio, N; Roccatagliata, L
Spastic dystonia in multiple sclerosis: the dark side of muscle hypertonia
2020-01-01 Bodrero, M.; Di Giovanni, R.; Capello, E.; Marinelli, L.; Mori, L.; Puce, L.; Curra, A.; Masuccio, F. G.; Solaro, C.; Trompetto, C.
Spasticity and spastic dystonia: the two faces of velocity-dependent hypertonia
2017-01-01 Marinelli, Lucio; Currà, Antonio; Trompetto, Carlo; Capello, Elisabetta; Serrati, Carlo; Fattapposta, Francesco; Pelosin, Elisa; Phadke, Chetan; Aymard, Claire; Puce, Luca; Molteni, Franco; Abbruzzese, Giovanni; Bandini, Fabio
Spasticity, spastic dystonia, and static stretch reflex in hypertonic muscles of patients with multiple sclerosis
2021-01-01 Puce, L.; Curra, A.; Marinelli, L.; Mori, L.; Capello, E.; Di Giovanni, R.; Bodrero, M.; Solaro, C.; Cotellessa, F.; Fattapposta, F.; Trompetto, C.
The early effect of cladribrine versus fingolimod on clinical and MRI measures in relapsing remitting multiple sclerosis
2023-01-01 Sirito, T; Boffa, G; Lapucci, C; Boccia, Vd; Aluan, K; Roccatagliata, L; Uccelli, A; Laroni, A; Capello, E; Cellerino, M; Inglese, M
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity
2016-01-01 Marinelli, Lucio; Mori, Laura; Canneva, Stefania; Colombano, Federica; Currà, Antonio; Fattapposta, Francesco; Bandini, Fabio; Capello, Elisabetta; Abbruzzese, Giovanni; Trompetto, Carlo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| An eleven-year history of Vanishing White Matter Disease in an adult patient with no cognitive decline and EIF2B5 mutations. A case report | 1-gen-2021 | Trevisan, L.; Grazzini, M.; Cianflone, A.; Accogli, A.; Finocchi, C.; Capello, E.; Saitta, L.; Grandis, M.; Roccatagliata, L.; Mandich, P. | |
| Effect of ocrelizumab treatment on retinal atrophy: preliminary results from a single-center observational study | 1-gen-2022 | Cellerino, M; Mancuso, E; Boffa, G; Bruschi, N; Novi, G; Magon, S; Gaetano, L; Uccelli, A; Capello, E; Laroni, A; Lapucci, C; Inglese, M | |
| Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population | 1-gen-2020 | Boffa, G; Bruschi, N; Cellerino, M; Lapucci, C; Novi, G; Sbragia, E; Capello, E; Uccelli, A; Inglese, M. | |
| Guillain barré syndrome of axonal type in a multple sclerosis patient: Fortuitous association or linked disorders? | 1-gen-1997 | Roccatagliata, L.; Capello, E.; Schenone, A.; Inglese, M.; Nobbio, L.; Grandis, M.; Maritato, F.; Abbruzzese, M.; Mancardi, G. L. | |
| Long-term assessment of the cognitive effects of nabiximols in patients with multiple sclerosis: A pilot study | 1-gen-2020 | Alessandria, G.; Meli, R.; Infante, M. T.; Vestito, L.; Capello, E.; Bandini, F. | |
| MRI and neuropathologic study of eae in the non human primate callithr1x jacchus | 1-gen-1997 | Mancardi, G. L.; Capello, E.; Massacesi, L.; Inglese, M.; Giunti, D.; Nicolay, K.; 'T Hart, B. A.; Uccelli, A. | |
| Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? | 1-gen-2021 | Tazza, F.; Lapucci, C.; Cellerino, M.; Boffa, G.; Novi, G.; Poire, I.; Mancuso, E.; Bruschi, N.; Sbragia, E.; Laroni, A.; Capello, E.; Inglese, M. | |
| Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis | 1-gen-2021 | Cellerino, M.; Boffa, G.; Lapucci, C.; Tazza, F.; Sbragia, E.; Mancuso, E.; Bruschi, N.; Minguzzi, S.; Ivaldi, F.; Poire, I.; Laroni, A.; Mancardi, G.; Capello, E.; Uccelli, A.; Novi, G.; Inglese, M. | |
| Rapidly ascending necrotizing myelopathy with widespread brain white matter involvement following intrathecal methotrexate and cytosine arabinoside treatment in an adult with T cell acute lymphoblastic leukemia | 1-gen-2018 | Lapucci, C; Capello, E; Romano, N; Guolo, F; Mavilio, N; Roccatagliata, L | |
| Spastic dystonia in multiple sclerosis: the dark side of muscle hypertonia | 1-gen-2020 | Bodrero, M.; Di Giovanni, R.; Capello, E.; Marinelli, L.; Mori, L.; Puce, L.; Curra, A.; Masuccio, F. G.; Solaro, C.; Trompetto, C. | |
| Spasticity and spastic dystonia: the two faces of velocity-dependent hypertonia | 1-gen-2017 | Marinelli, Lucio; Currà, Antonio; Trompetto, Carlo; Capello, Elisabetta; Serrati, Carlo; Fattapposta, Francesco; Pelosin, Elisa; Phadke, Chetan; Aymard, Claire; Puce, Luca; Molteni, Franco; Abbruzzese, Giovanni; Bandini, Fabio | |
| Spasticity, spastic dystonia, and static stretch reflex in hypertonic muscles of patients with multiple sclerosis | 1-gen-2021 | Puce, L.; Curra, A.; Marinelli, L.; Mori, L.; Capello, E.; Di Giovanni, R.; Bodrero, M.; Solaro, C.; Cotellessa, F.; Fattapposta, F.; Trompetto, C. | |
| The early effect of cladribrine versus fingolimod on clinical and MRI measures in relapsing remitting multiple sclerosis | 1-gen-2023 | Sirito, T; Boffa, G; Lapucci, C; Boccia, Vd; Aluan, K; Roccatagliata, L; Uccelli, A; Laroni, A; Capello, E; Cellerino, M; Inglese, M | |
| The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity | 1-gen-2016 | Marinelli, Lucio; Mori, Laura; Canneva, Stefania; Colombano, Federica; Currà, Antonio; Fattapposta, Francesco; Bandini, Fabio; Capello, Elisabetta; Abbruzzese, Giovanni; Trompetto, Carlo |